Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
56
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Hodges Michael R. | Director | 2 | $0 | $0 | 2024-07-24 |
| Krueger Todd | Director | 2 | $0 | $0 | 2024-07-24 |
| Weissman James B | Director | 2 | $0 | $0 | 2024-07-24 |
| Hlavinka Sarah E. | Director | 2 | $0 | $0 | 2024-07-24 |
| Golub Steven J | Director | 2 | $0 | $0 | 2024-07-24 |
| TUMOLO ANNETTE | Director | 4 | $0 | $0 | 2024-05-01 |
| Witney Frank | Director | 4 | $0 | $0 | 2024-05-01 |
| Herrema Gregory J. | Director | 4 | $0 | $0 | 2024-05-01 |
| TSINGOS CHRISTINE A | Director | 4 | $0 | $0 | 2024-05-01 |
| NACHTSHEIM JAMI K | Director | 4 | $0 | $0 | 2024-05-01 |
| Esser Eric Eugene | President & COO | 5 | $0 | $0 | 2024-04-17 |
| Nelson Todd Robert | President & CEO | 8 | $0 | $7.3K | 2024-03-01 |
| Gibson Daniel Glenn | Chief Technology Officer | 5 | $0 | $3.4K | 2024-03-01 |
| Cutler Rob | Chief Legal Officer | 5 | $0 | $3.3K | 2024-03-01 |
| KULLBACK WILLIAM J | Chief Financial Officer | 1 | $0 | $0 | 2023-08-31 |
| MEISTER PAUL M | Director, 10% Owner | 2 | $0 | $0 | 2023-06-06 |
| Northpond Ventures GP, LLC | Director, 10% Owner | 3 | $0 | $0 | 2023-06-05 |
| BroadOak Fund IV, LLC | 10% Owner | 3 | $0 | $0 | 2023-06-05 |
| Snider William | Director, 10% Owner | 3 | $0 | $0 | 2023-06-05 |
| KLARMAN SETH A | 10% Owner | 2 | $11.00M | $0 | 2021-09-14 |
| Smith Brendan | Chief Financial Officer | 2 | $0 | $0 | 2021-09-14 |
| Sutherland Everett Rand | President | 2 | $0 | $0 | 2021-09-14 |
| Plenge Robert M | Director | 8 | $0 | $0 | 2021-09-14 |
| Burgess Paul D. | Chief Operating Officer, CLO | 9 | $0 | $2.73M | 2021-09-14 |
| Meyer Robert J. | Director | 8 | $0 | $0 | 2021-09-14 |
| Demetri George | Director | 9 | $0 | $0 | 2021-09-14 |
| Hughes Owen | Director | 8 | $0 | $1.13M | 2021-09-14 |
| Beckman Daniella | Director | 7 | $0 | $0 | 2021-09-14 |
| Renaud Ronald C JR | See Remarks | 27 | $0 | $36.25M | 2021-09-14 |
| Sanofi | 10% Owner | 2 | $2.74B | $0 | 2021-09-14 |
| FORMELA JEAN FRANCOIS | Director | 18 | $0 | $82.92M | 2021-09-14 |
| Wooster Richard | Chief Scientific Officer | 3 | $0 | $0 | 2021-03-09 |
| Barbier Ann | Chief Medical Officer | 3 | $0 | $0 | 2021-03-09 |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | 2 | $0 | $141.93M | 2020-06-30 |
| LYNCH DANIEL | Director | 2 | $0 | $0 | 2020-06-16 |
| Shire Human Genetic Therapies, Inc. | 10% Owner | 4 | $0 | $4.24M | 2020-06-02 |
| Schroer John R. | Chief Financial Officer | 2 | $0 | $0 | 2020-03-03 |
| Fenton Brian | Chief Business Officer | 1 | $0 | $0 | 2019-03-08 |
| Cloghessy Paula | Chief Human Resources Officer | 1 | $0 | $0 | 2019-03-08 |
| Heartlein Michael | Chief Scientific Officer | 1 | $0 | $0 | 2019-03-08 |
| Shire plc | 10% Owner | 1 | $0 | $0 | 2018-07-02 |
| MRL Ventures Fund LLC | 10% Owner | 4 | $325.0K | $0 | 2018-07-02 |
| Gallagher Brian M. Jr. | Director | 7 | $3.50M | $0 | 2018-07-02 |
| Omega Fund IV GP, L.P. | 10% Owner | 16 | $0 | $0 | 2018-07-02 |
| Atlas Venture Associates VIII, L.P. | 10% Owner | 4 | $0 | $0 | 2018-07-02 |
| GLAXOSMITHKLINE PLC | 10% Owner | 7 | $3.50M | $0 | 2018-07-02 |
| KIRK RANDAL J | 10% Owner | 46 | $5.84M | $1.98M | 2017-06-29 |
| Thomae Mya | Director | 3 | $0 | $0 | 2016-12-13 |
| Luther Michael A | Director | 4 | $0 | $0 | 2016-12-13 |
| Patzig Robert | Director | 4 | $0 | $0 | 2016-12-13 |
| Koppler Doit II | Director | 3 | $0 | $0 | 2016-12-13 |
| Kinnon Paul | CEO, President and Interim CFO | 3 | $0 | $0 | 2015-04-01 |
| Richards Leon | Chief Accounting Officer | 3 | $0 | $0 | 2015-04-01 |
| THOMPSON JOHN D | Director | 4 | $0 | $0 | 2015-04-01 |
| Kopp LeRoy C | 10% Owner | 3 | $3.5K | $1.56M | 2014-05-22 |
| COLONNESE MARK P | Chief Financial Officer | 2 | $0 | $0 | 2013-09-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Weissman James B | Director | A Award deriv | 2024-07-24 | 2024-07-26 | 5,268 | — | $0 | 5,268 | SEC↗ |
| Hodges Michael R. | Director | A Award deriv | 2024-07-24 | 2024-07-26 | 5,268 | — | $0 | 5,268 | SEC↗ |
| Hlavinka Sarah E. | Director | A Award deriv | 2024-07-24 | 2024-07-26 | 5,268 | — | $0 | 5,268 | SEC↗ |
| Golub Steven J | Director | A Award deriv | 2024-07-24 | 2024-07-26 | 5,268 | — | $0 | 5,268 | SEC↗ |
| Krueger Todd | Director | A Award deriv | 2024-07-24 | 2024-07-26 | 5,268 | — | $0 | 5,268 | SEC↗ |
| Weissman James B | Director | A Award | 2024-07-24 | 2024-07-26 | 8,390 | — | $0 | 8,390 | SEC↗ |
| Hodges Michael R. | Director | A Award | 2024-07-24 | 2024-07-26 | 8,390 | — | $0 | 8,390 | SEC↗ |
| Hlavinka Sarah E. | Director | A Award | 2024-07-24 | 2024-07-26 | 8,390 | — | $0 | 8,390 | SEC↗ |
| Golub Steven J | Director | A Award | 2024-07-24 | 2024-07-26 | 8,390 | — | $0 | 8,390 | SEC↗ |
| Krueger Todd | Director | A Award | 2024-07-24 | 2024-07-26 | 8,390 | — | $0 | 8,390 | SEC↗ |
| Herrema Gregory J. | Director | A Award deriv | 2024-05-01 | 2024-05-03 | 30,362 | — | $0 | 30,362 | SEC↗ |
| NACHTSHEIM JAMI K | Director | A Award deriv | 2024-05-01 | 2024-05-03 | 30,362 | — | $0 | 30,362 | SEC↗ |
| TSINGOS CHRISTINE A | Director | A Award deriv | 2024-05-01 | 2024-05-03 | 30,362 | — | $0 | 30,362 | SEC↗ |
| TUMOLO ANNETTE | Director | A Award deriv | 2024-05-01 | 2024-05-03 | 30,362 | — | $0 | 30,362 | SEC↗ |
| Witney Frank | Director | A Award deriv | 2024-05-01 | 2024-05-03 | 30,362 | — | $0 | 30,362 | SEC↗ |
| Herrema Gregory J. | Director | A Award | 2024-05-01 | 2024-05-03 | 31,486 | — | $0 | 184,677 | SEC↗ |
| NACHTSHEIM JAMI K | Director | A Award | 2024-05-01 | 2024-05-03 | 34,297 | — | $0 | 101,679 | SEC↗ |
| TSINGOS CHRISTINE A | Director | A Award | 2024-05-01 | 2024-05-03 | 37,109 | — | $0 | 104,491 | SEC↗ |
| TUMOLO ANNETTE | Director | A Award | 2024-05-01 | 2024-05-03 | 36,406 | — | $0 | 157,769 | SEC↗ |
| Witney Frank | Director | A Award | 2024-05-01 | 2024-05-03 | 48,354 | — | $0 | 115,736 | SEC↗ |
| Esser Eric Eugene | President & CEO | A Award deriv | 2024-04-17 | 2024-04-19 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Esser Eric Eugene | President & CEO | A Award | 2024-04-17 | 2024-04-19 | 100,000 | — | $0 | 129,260 | SEC↗ |
| Cutler Rob | Chief Legal Officer | F Tax w/h | 2024-03-01 | 2024-03-05 | 1,376 | $0.53 | $729 | 35,718 | SEC↗ |
| Gibson Daniel Glenn | Chief Technology Officer | F Tax w/h | 2024-03-01 | 2024-03-05 | 656 | $0.53 | $348 | 105,562 | SEC↗ |
| Esser Eric Eugene | President & COO | F Tax w/h | 2024-03-01 | 2024-03-05 | 3,340 | $0.53 | $1.8K | 29,260 | SEC↗ |
| Nelson Todd Robert | Chief Executive Officer | F Tax w/h | 2024-03-01 | 2024-03-05 | 4,756 | $0.53 | $2.5K | 174,240 | SEC↗ |
| Cutler Rob | Chief Legal Officer | F Tax w/h | 2024-02-27 | 2024-02-29 | 2,174 | $0.53 | $1.2K | 23,294 | SEC↗ |
| Gibson Daniel Glenn | Chief Technology Officer | F Tax w/h | 2024-02-27 | 2024-02-29 | 2,265 | $0.53 | $1.2K | 99,818 | SEC↗ |
| Nelson Todd Robert | President & CEO | F Tax w/h | 2024-02-27 | 2024-02-29 | 4,776 | $0.53 | $2.5K | 131,296 | SEC↗ |
| Herrema Gregory J. | Director | A Award deriv | 2023-10-18 | 2023-10-25 | 229,787 | — | $0 | 229,787 | SEC↗ |
| Herrema Gregory J. | Director | A Award | 2023-10-18 | 2023-10-25 | 153,191 | — | $0 | 153,191 | SEC↗ |
| KULLBACK WILLIAM J | Chief Financial Officer | A Award deriv | 2023-08-31 | 2023-12-05 | 300,000 | — | $0 | 300,000 | SEC↗ |
| NACHTSHEIM JAMI K | Director | A Award deriv | 2023-07-06 | 2024-05-03 | 70,129 | — | $0 | 70,129 | SEC↗ |
| TSINGOS CHRISTINE A | Director | A Award deriv | 2023-07-06 | 2024-05-03 | 70,129 | — | $0 | 70,129 | SEC↗ |
| TUMOLO ANNETTE | Director | A Award deriv | 2023-07-06 | 2024-05-03 | 70,129 | — | $0 | 70,129 | SEC↗ |
| Witney Frank | Director | A Award deriv | 2023-07-06 | 2024-05-03 | 70,129 | — | $0 | 70,129 | SEC↗ |
| NACHTSHEIM JAMI K | Director | A Award | 2023-07-06 | 2024-05-03 | 46,752 | — | $0 | 67,382 | SEC↗ |
| TSINGOS CHRISTINE A | Director | A Award | 2023-07-06 | 2024-05-03 | 46,752 | — | $0 | 67,382 | SEC↗ |
| TUMOLO ANNETTE | Director | A Award | 2023-07-06 | 2024-05-03 | 46,752 | — | $0 | 121,363 | SEC↗ |
| Witney Frank | Director | A Award | 2023-07-06 | 2024-05-03 | 46,752 | — | $0 | 67,382 | SEC↗ |
| Cutler Rob | Chief Legal Officer | A Award deriv | 2023-06-22 | 2024-03-05 | 111,800 | — | $0 | 111,800 | SEC↗ |
| Gibson Daniel Glenn | Chief Technology Officer | A Award deriv | 2023-06-22 | 2024-03-05 | 51,500 | — | $0 | 51,500 | SEC↗ |
| Esser Eric Eugene | President & COO | A Award deriv | 2023-06-22 | 2024-03-05 | 263,600 | — | $0 | 263,600 | SEC↗ |
| Nelson Todd Robert | Chief Executive Officer | A Award deriv | 2023-06-22 | 2024-03-05 | 385,500 | — | $0 | 385,500 | SEC↗ |
| Cutler Rob | Chief Legal Officer | A Award | 2023-06-22 | 2024-03-05 | 13,800 | — | $0 | 37,094 | SEC↗ |
| Gibson Daniel Glenn | Chief Technology Officer | A Award | 2023-06-22 | 2024-03-05 | 6,400 | — | $0 | 106,218 | SEC↗ |
| Esser Eric Eugene | President & COO | A Award | 2023-06-22 | 2024-03-05 | 32,600 | — | $0 | 32,600 | SEC↗ |
| Nelson Todd Robert | Chief Executive Officer | A Award | 2023-06-22 | 2024-03-05 | 47,700 | — | $0 | 178,996 | SEC↗ |
| MEISTER PAUL M | Director, 10% Owner | A Award deriv | 2023-06-06 | 2023-06-08 | 162,406 | — | $0 | 162,406 | SEC↗ |
| MEISTER PAUL M | Director, 10% Owner | A Award | 2023-06-06 | 2023-06-08 | 108,270 | — | $0 | 108,270 | SEC↗ |
| Nelson Todd Robert | President & CEO | A Award deriv | 2023-06-05 | 2023-06-07 | 528,922 | — | $0 | 528,922 | SEC↗ |
| Nelson Todd Robert | President & CEO | A Award deriv | 2023-06-05 | 2023-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Nelson Todd Robert | President & CEO | A Award deriv | 2023-06-05 | 2023-06-07 | 1,057,843 | — | $0 | 1,057,843 | SEC↗ |
| Snider William | Director, 10% Owner | A Award deriv | 2023-06-05 | 2023-06-07 | 846,274 | — | $0 | 846,274 | SEC↗ |
| Snider William | Director, 10% Owner | A Award deriv | 2023-06-05 | 2023-06-07 | 423,137 | — | $0 | 423,137 | SEC↗ |
| Snider William | Director, 10% Owner | A Award deriv | 2023-06-05 | 2023-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BroadOak Fund IV, LLC | 10% Owner | A Award deriv | 2023-06-05 | 2023-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BroadOak Fund IV, LLC | 10% Owner | A Award deriv | 2023-06-05 | 2023-06-07 | 423,137 | — | $0 | 423,137 | SEC↗ |
| BroadOak Fund IV, LLC | 10% Owner | A Award deriv | 2023-06-05 | 2023-06-07 | 846,274 | — | $0 | 846,274 | SEC↗ |
| Northpond Ventures GP, LLC | Director, 10% Owner | A Award deriv | 2023-06-05 | 2023-06-07 | 1,692,549 | — | $0 | 1,692,549 | SEC↗ |
| Northpond Ventures GP, LLC | Director, 10% Owner | A Award deriv | 2023-06-05 | 2023-06-07 | 3,385,097 | — | $0 | 3,385,097 | SEC↗ |
| Northpond Ventures GP, LLC | Director, 10% Owner | A Award deriv | 2023-06-05 | 2023-06-07 | 80,000 | $100.00 | $8.00M | 3,385,097 | SEC↗ |
| Cutler Rob | Chief Legal Officer | S Sale | 2023-05-04 | 2023-05-08 | 1,174 | $2.83 | $3.3K | 25,468 | SEC↗ |
| Gibson Daniel Glenn | Chief Technology Officer | S Sale | 2023-05-04 | 2023-05-08 | 1,190 | $2.83 | $3.4K | 102,083 | SEC↗ |
| Nelson Todd Robert | President & CEO | S Sale | 2023-05-04 | 2023-05-08 | 2,575 | $2.83 | $7.3K | 136,072 | SEC↗ |
| Beckman Daniella | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 20,000 | — | $0 | 0 | SEC↗ |
| Beckman Daniella | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| Beckman Daniella | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| Beckman Daniella | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 67,995 | — | $0 | 0 | SEC↗ |
| Demetri George | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| Demetri George | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 20,000 | — | $0 | 0 | SEC↗ |
| Demetri George | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 37,800 | — | $0 | 0 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 20,000 | — | $0 | 0 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 37,800 | — | $0 | 0 | SEC↗ |
| Demetri George | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| Demetri George | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 37,800 | — | $0 | 0 | SEC↗ |
| Demetri George | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 20,000 | — | $0 | 0 | SEC↗ |
| Hughes Owen | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| Hughes Owen | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 20,000 | — | $0 | 0 | SEC↗ |
| Hughes Owen | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| Hughes Owen | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 38,135 | — | $0 | 0 | SEC↗ |
| Meyer Robert J. | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| Meyer Robert J. | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| Meyer Robert J. | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 20,000 | — | $0 | 0 | SEC↗ |
| Meyer Robert J. | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 37,800 | — | $0 | 0 | SEC↗ |
| Plenge Robert M | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 20,000 | — | $0 | 0 | SEC↗ |
| Plenge Robert M | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| Plenge Robert M | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 37,800 | — | $0 | 0 | SEC↗ |
| Plenge Robert M | Director | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| Burgess Paul D. | Chief Operating Officer, CLO | S Sale deriv | 2021-09-14 | 2021-09-14 | 150,000 | — | $0 | 0 | SEC↗ |
| Burgess Paul D. | Chief Operating Officer, CLO | S Sale deriv | 2021-09-14 | 2021-09-14 | 90,000 | — | $0 | 0 | SEC↗ |
| Burgess Paul D. | Chief Operating Officer, CLO | S Sale deriv | 2021-09-14 | 2021-09-14 | 150,000 | — | $0 | 0 | SEC↗ |
| Burgess Paul D. | Chief Operating Officer, CLO | S Sale deriv | 2021-09-14 | 2021-09-14 | 69,953 | — | $0 | 0 | SEC↗ |
| Burgess Paul D. | Chief Operating Officer, CLO | S Sale deriv | 2021-09-14 | 2021-09-14 | 219,652 | — | $0 | 0 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | S Sale deriv | 2021-09-14 | 2021-09-14 | 500,000 | — | $0 | 0 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | S Sale deriv | 2021-09-14 | 2021-09-14 | 525,000 | — | $0 | 0 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | S Sale deriv | 2021-09-14 | 2021-09-14 | 325,000 | — | $0 | 0 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | S Sale deriv | 2021-09-14 | 2021-09-14 | 1,071,009 | — | $0 | 0 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | S Sale deriv | 2021-09-14 | 2021-09-14 | 89,996 | — | $0 | 0 | SEC↗ |
| Smith Brendan | Chief Financial Officer | S Sale deriv | 2021-09-14 | 2021-09-14 | 201,800 | — | $0 | 0 | SEC↗ |
| Sutherland Everett Rand | President | S Sale deriv | 2021-09-14 | 2021-09-14 | 300,000 | — | $0 | 0 | SEC↗ |
| Sanofi | 10% Owner | P Buy | 2021-09-14 | 2021-09-14 | 51,467,612 | $38.00 | $1.96B | 55,152,046 | SEC↗ |
| Sanofi | 10% Owner | P Buy | 2021-09-14 | 2021-09-14 | 20,515,985 | $38.00 | $779.61M | 75,668,031 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | S Sale | 2021-09-14 | 2021-09-14 | 2,055,063 | $38.00 | $78.09M | 0 | SEC↗ |
| Hughes Owen | Director | S Sale | 2021-09-14 | 2021-09-14 | 29,860 | $38.00 | $1.13M | 0 | SEC↗ |
| Burgess Paul D. | Chief Operating Officer, CLO | S Sale | 2021-09-14 | 2021-09-14 | 71,833 | $38.00 | $2.73M | 0 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | S Sale | 2021-09-14 | 2021-09-14 | 409,913 | $38.00 | $15.58M | 0 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | S Sale | 2021-09-14 | 2021-09-14 | 40,909 | $38.00 | $1.55M | 0 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | S Sale | 2021-09-14 | 2021-09-14 | 503,231 | $38.00 | $19.12M | 0 | SEC↗ |
| KLARMAN SETH A | 10% Owner | J Other | 2021-09-14 | 2021-09-16 | 18,044,239 | $38.00 | $685.68M | 0 | SEC↗ |
| Demetri George | Director | A Award deriv | 2021-06-16 | 2021-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Hughes Owen | Director | A Award deriv | 2021-06-16 | 2021-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Meyer Robert J. | Director | A Award deriv | 2021-06-16 | 2021-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Plenge Robert M | Director | A Award deriv | 2021-06-16 | 2021-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Beckman Daniella | Director | A Award deriv | 2021-06-16 | 2021-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Smith Brendan | Chief Financial Officer | A Award deriv | 2021-04-19 | 2021-04-20 | 201,800 | — | $0 | 201,800 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | M Exercise deriv | 2021-04-07 | 2021-09-14 | 9,026 | — | $0 | 1,071,009 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | M Exercise | 2021-04-07 | 2021-09-14 | 9,026 | $7.39 | $66.7K | 503,231 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | M Exercise deriv | 2021-04-07 | 2021-04-09 | 9,026 | — | $0 | 1,071,009 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | M Exercise | 2021-04-07 | 2021-04-09 | 9,026 | $7.39 | $66.7K | 503,321 | SEC↗ |
| Sutherland Everett Rand | President | A Award deriv | 2021-03-22 | 2021-03-23 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Burgess Paul D. | Chief Operating Officer, CLO | A Award deriv | 2021-03-09 | 2021-03-09 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Barbier Ann | Chief Medical Officer | A Award deriv | 2021-03-09 | 2021-03-09 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Wooster Richard | Chief Scientific Officer | A Award deriv | 2021-03-09 | 2021-03-09 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer, Pre | A Award deriv | 2021-03-09 | 2021-03-09 | 325,000 | — | $0 | 325,000 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer, Pre | M Exercise deriv | 2021-01-14 | 2021-01-14 | 5,638 | — | $0 | 1,080,035 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer, Pre | M Exercise deriv | 2021-01-14 | 2021-01-14 | 1 | — | $0 | 89,996 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer, Pre | M Exercise | 2021-01-14 | 2021-01-14 | 5,638 | $7.39 | $41.7K | 494,204 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer, Pre | M Exercise | 2021-01-14 | 2021-01-14 | 1 | $8.34 | $8 | 494,205 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | S Sale | 2020-12-22 | 2020-12-23 | 79,865 | $25.04 | $2.00M | 46,640 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | S Sale | 2020-12-22 | 2020-12-23 | 2,700 | $25.88 | $69.9K | 43,940 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | S Sale | 2020-12-21 | 2020-12-23 | 56,536 | $25.50 | $1.44M | 126,505 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer, Pre | M Exercise deriv | 2020-11-16 | 2020-11-18 | 53,004 | — | $0 | 1,085,673 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer, Pre | M Exercise deriv | 2020-11-16 | 2020-11-18 | 3 | — | $0 | 89,997 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer, Pre | M Exercise | 2020-11-16 | 2020-11-18 | 3 | $8.34 | $25 | 488,566 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer, Pre | M Exercise | 2020-11-16 | 2020-11-18 | 53,004 | $7.39 | $391.7K | 488,563 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | S Sale | 2020-08-27 | 2020-08-27 | 10,097 | $14.38 | $145.2K | 3,833,122 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | S Sale | 2020-08-26 | 2020-08-27 | 44,381 | $14.80 | $656.8K | 3,843,219 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | S Sale | 2020-08-25 | 2020-08-27 | 34,410 | $15.00 | $516.1K | 3,887,600 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2020-06-30 | 2020-06-30 | 6,824,992 | $20.68 | $141.14M | 0 | SEC↗ |
| KLARMAN SETH A | 10% Owner | P Buy | 2020-06-26 | 2020-06-30 | 500,000 | $22.00 | $11.00M | 18,044,239 | SEC↗ |
| Demetri George | Director | A Award deriv | 2020-06-16 | 2020-06-16 | 18,900 | — | $0 | 18,900 | SEC↗ |
| Hughes Owen | Director | A Award deriv | 2020-06-16 | 2020-06-16 | 18,900 | — | $0 | 18,900 | SEC↗ |
| Meyer Robert J. | Director | A Award deriv | 2020-06-16 | 2020-06-16 | 18,900 | — | $0 | 18,900 | SEC↗ |
| Plenge Robert M | Director | A Award deriv | 2020-06-16 | 2020-06-16 | 18,900 | — | $0 | 18,900 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | A Award deriv | 2020-06-16 | 2020-06-17 | 18,900 | — | $0 | 18,900 | SEC↗ |
| Beckman Daniella | Director | A Award deriv | 2020-06-16 | 2020-06-17 | 18,900 | — | $0 | 18,900 | SEC↗ |
| LYNCH DANIEL | Director | A Award deriv | 2020-06-16 | 2020-06-17 | 18,900 | — | $0 | 18,900 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2020-06-03 | 2020-06-05 | 40,086 | $19.75 | $791.7K | 6,824,992 | SEC↗ |
| Shire Human Genetic Therapies, | 10% Owner | S Sale | 2020-06-02 | 2020-06-03 | 5,006 | $20.02 | $100.2K | 6,865,078 | SEC↗ |
| Shire Human Genetic Therapies, | 10% Owner | S Sale | 2020-06-02 | 2020-06-03 | 100,389 | $19.75 | $1.98M | 6,870,084 | SEC↗ |
| Shire Human Genetic Therapies, | 10% Owner | S Sale | 2020-06-01 | 2020-06-03 | 1,400 | $20.53 | $28.7K | 6,970,473 | SEC↗ |
| Shire Human Genetic Therapies, | 10% Owner | S Sale | 2020-06-01 | 2020-06-03 | 107,072 | $19.85 | $2.13M | 6,971,873 | SEC↗ |
| Barbier Ann | Chief Medical Officer | A Award deriv | 2020-03-03 | 2020-03-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Burgess Paul D. | Chief Operating Officer, CLO | A Award deriv | 2020-03-03 | 2020-03-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | A Award deriv | 2020-03-03 | 2020-03-05 | 525,000 | — | $0 | 525,000 | SEC↗ |
| Schroer John R. | Chief Financial Officer | A Award deriv | 2020-03-03 | 2020-03-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Wooster Richard | Chief Scientific Officer | A Award deriv | 2020-03-03 | 2020-03-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Demetri George | Director | A Award deriv | 2019-07-12 | 2019-07-15 | 37,800 | — | $0 | 37,800 | SEC↗ |
| Beckman Daniella | Director | A Award deriv | 2019-06-18 | 2019-06-19 | 18,900 | — | $0 | 18,900 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | A Award deriv | 2019-06-18 | 2019-06-19 | 18,900 | — | $0 | 18,900 | SEC↗ |
| Hughes Owen | Director | A Award deriv | 2019-06-18 | 2019-06-19 | 18,900 | — | $0 | 18,900 | SEC↗ |
| LYNCH DANIEL | Director | A Award deriv | 2019-06-18 | 2019-06-19 | 18,900 | — | $0 | 18,900 | SEC↗ |
| Meyer Robert J. | Director | A Award deriv | 2019-06-18 | 2019-06-19 | 18,900 | — | $0 | 18,900 | SEC↗ |
| Plenge Robert M | Director | A Award deriv | 2019-06-18 | 2019-06-19 | 18,900 | — | $0 | 18,900 | SEC↗ |
| Wooster Richard | Chief Scientific Officer | A Award deriv | 2019-04-24 | 2019-04-26 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Plenge Robert M | Director | A Award deriv | 2019-04-10 | 2019-04-11 | 37,800 | — | $0 | 37,800 | SEC↗ |
| Barbier Ann | Chief Medical Officer | A Award deriv | 2019-03-08 | 2019-03-12 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Burgess Paul D. | Chief Legal Officer | A Award deriv | 2019-03-08 | 2019-03-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Cloghessy Paula | Chief Human Resources Office | A Award deriv | 2019-03-08 | 2019-03-12 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Fenton Brian | Chief Business Officer | A Award deriv | 2019-03-08 | 2019-03-12 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Heartlein Michael | Chief Scientific Officer | A Award deriv | 2019-03-08 | 2019-03-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Renaud Ronald C JR | Chief Executive Officer | A Award deriv | 2019-03-08 | 2019-03-12 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Schroer John R. | Chief Financial Officer | A Award deriv | 2019-03-08 | 2019-03-12 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Meyer Robert J. | Director | A Award deriv | 2019-01-02 | 2019-01-03 | 37,800 | — | $0 | 37,800 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 7,222,797 | — | $0 | 0 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 2,525,253 | — | $0 | 0 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 9,300,000 | — | $0 | 0 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | C Conversion deriv | 2018-07-02 | 2018-07-03 | 2,525,253 | — | $0 | 0 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | C Conversion deriv | 2018-07-02 | 2018-07-03 | 5,838,230 | — | $0 | 0 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | C Conversion deriv | 2018-07-02 | 2018-07-03 | 12,925,244 | — | $0 | 0 | SEC↗ |
| Atlas Venture Associates VIII, | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 5,838,230 | — | $0 | 0 | SEC↗ |
| Atlas Venture Associates VIII, | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 2,525,253 | — | $0 | 0 | SEC↗ |
| Atlas Venture Associates VIII, | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 12,925,244 | — | $0 | 0 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 2,500,000 | — | $0 | 0 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 2,500,000 | — | $0 | 0 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 1,676,348 | — | $0 | 0 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 1,676,348 | — | $0 | 0 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 1,263,484 | — | $0 | 0 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 1,263,484 | — | $0 | 0 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 302,173 | — | $0 | 0 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 302,173 | — | $0 | 0 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 2,000,103 | — | $0 | 0 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 2,000,103 | — | $0 | 0 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 5,800,000 | — | $0 | 0 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 5,800,000 | — | $0 | 0 | SEC↗ |
| MRL Ventures Fund LLC | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 9,259,259 | — | $0 | 0 | SEC↗ |
| MRL Ventures Fund LLC | 10% Owner | C Conversion deriv | 2018-07-02 | 2018-07-03 | 1,010,101 | — | $0 | 0 | SEC↗ |
| Renaud Ronald C JR | See Remarks | C Conversion deriv | 2018-07-02 | 2018-07-03 | 227,272 | — | $0 | 0 | SEC↗ |
| Renaud Ronald C JR | See Remarks | C Conversion deriv | 2018-07-02 | 2018-07-03 | 227,272 | — | $0 | 0 | SEC↗ |
| Gallagher Brian M. Jr. | Director | C Conversion deriv | 2018-07-02 | 2018-07-05 | 2,525,253 | — | $0 | 0 | SEC↗ |
| Gallagher Brian M. Jr. | Director | C Conversion deriv | 2018-07-02 | 2018-07-05 | 7,222,797 | — | $0 | 0 | SEC↗ |
| Gallagher Brian M. Jr. | Director | C Conversion deriv | 2018-07-02 | 2018-07-05 | 9,300,000 | — | $0 | 0 | SEC↗ |
| Shire plc | 10% Owner | J Other | 2018-07-02 | 2018-07-02 | 183,619 | — | $0 | 7,078,945 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | C Conversion | 2018-07-02 | 2018-07-03 | 1,674,016 | — | $0 | 1,674,016 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | C Conversion | 2018-07-02 | 2018-07-03 | 454,550 | — | $0 | 3,428,682 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | P Buy | 2018-07-02 | 2018-07-03 | 269,230 | $13.00 | $3.50M | 3,697,912 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | C Conversion | 2018-07-02 | 2018-07-03 | 1,300,116 | — | $0 | 2,974,132 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | C Conversion | 2018-07-02 | 2018-07-03 | 3,832,010 | — | $0 | 3,922,010 | SEC↗ |
| Atlas Venture Associates VIII, | 10% Owner | C Conversion | 2018-07-02 | 2018-07-03 | 3,832,010 | — | $0 | 3,922,010 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion | 2018-07-02 | 2018-07-03 | 979,179 | — | $0 | 979,179 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion | 2018-07-02 | 2018-07-03 | 979,179 | — | $0 | 979,179 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion | 2018-07-02 | 2018-07-03 | 1,458,424 | — | $0 | 1,458,424 | SEC↗ |
| Omega Fund IV GP, L.P. | 10% Owner | C Conversion | 2018-07-02 | 2018-07-03 | 1,458,424 | — | $0 | 1,458,424 | SEC↗ |
| MRL Ventures Fund LLC | 10% Owner | P Buy | 2018-07-02 | 2018-07-03 | 25,000 | $13.00 | $325.0K | 1,873,503 | SEC↗ |
| MRL Ventures Fund LLC | 10% Owner | C Conversion | 2018-07-02 | 2018-07-03 | 1,848,503 | — | $0 | 1,848,503 | SEC↗ |
| Renaud Ronald C JR | See Remarks | C Conversion | 2018-07-02 | 2018-07-03 | 40,909 | — | $0 | 409,913 | SEC↗ |
| Renaud Ronald C JR | See Remarks | C Conversion | 2018-07-02 | 2018-07-03 | 40,909 | — | $0 | 40,909 | SEC↗ |
| Gallagher Brian M. Jr. | Director | C Conversion | 2018-07-02 | 2018-07-05 | 1,674,016 | — | $0 | 1,674,016 | SEC↗ |
| Gallagher Brian M. Jr. | Director | P Buy | 2018-07-02 | 2018-07-05 | 269,230 | $13.00 | $3.50M | 3,697,912 | SEC↗ |
| Gallagher Brian M. Jr. | Director | C Conversion | 2018-07-02 | 2018-07-05 | 454,550 | — | $0 | 3,428,682 | SEC↗ |
| Gallagher Brian M. Jr. | Director | C Conversion | 2018-07-02 | 2018-07-05 | 1,300,116 | — | $0 | 2,974,132 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2017-06-29 | 2017-07-03 | 0 | — | $0 | 0 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy deriv | 2017-06-29 | 2017-07-03 | 42,941 | $3.74 | $160.6K | 321,170 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2017-06-29 | 2017-07-03 | 42,941 | — | $0 | 321,170 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2017-06-29 | 2017-07-03 | 160,585 | — | $0 | 141,052 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2017-06-29 | 2017-07-03 | 42,941 | — | $0 | 0 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy deriv | 2017-06-29 | 2017-07-03 | 321,170 | $3.74 | $1.20M | 321,170 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2017-06-29 | 2017-07-03 | 85,882 | — | $0 | 321,170 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2017-06-29 | 2017-07-03 | 321,170 | — | $0 | 141,052 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2017-06-29 | 2017-07-03 | 0 | — | $0 | 0 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy deriv | 2017-06-29 | 2017-07-03 | 0 | $3.74 | $0 | 160,585 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2017-06-29 | 2017-07-03 | 0 | — | $0 | 160,585 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2017-06-29 | 2017-07-03 | 0 | — | $0 | 70,526 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2017-06-29 | 2017-07-03 | 0 | — | $0 | 0 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion | 2017-06-29 | 2017-07-03 | 1,431 | — | $0 | 190,604 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion | 2017-06-29 | 2017-07-03 | 141,052 | $15.00 | $2.12M | 215,394 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion | 2017-06-29 | 2017-07-03 | 1,431 | — | $0 | 27,651 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion | 2017-06-29 | 2017-07-03 | 1,431 | — | $0 | 109,128 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion | 2017-06-29 | 2017-07-03 | 70,526 | $15.00 | $1.06M | 107,697 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion | 2017-06-29 | 2017-07-03 | 141,052 | $15.00 | $2.12M | 189,173 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion | 2017-06-29 | 2017-07-03 | 2,862 | — | $0 | 218,256 | SEC↗ |
| KIRK RANDAL J | 10% Owner | S Sale | 2017-06-08 | 2017-06-12 | 395,000 | $1.00 | $395.0K | 1,115,135 | SEC↗ |
| KIRK RANDAL J | 10% Owner | S Sale | 2017-06-08 | 2017-06-12 | 682,000 | $1.00 | $682.0K | 1,443,654 | SEC↗ |
| KIRK RANDAL J | 10% Owner | S Sale | 2017-06-08 | 2017-06-12 | 108,000 | $1.00 | $108.0K | 786,613 | SEC↗ |
| KIRK RANDAL J | 10% Owner | S Sale | 2017-06-08 | 2017-06-12 | 790,000 | $1.00 | $790.0K | 2,230,267 | SEC↗ |
| Luther Michael A | Director | A Award deriv | 2016-12-13 | 2016-12-15 | 5,000 | — | $0 | 105,000 | SEC↗ |
| Thomae Mya | Director | A Award deriv | 2016-12-13 | 2016-12-15 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Patzig Robert | Director | A Award deriv | 2016-12-13 | 2016-12-15 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Koppler Doit II | Director | A Award deriv | 2016-12-13 | 2016-12-15 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Koppler Doit II | Director | A Award deriv | 2016-10-06 | 2016-10-11 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Luther Michael A | Director | A Award deriv | 2016-10-06 | 2016-10-11 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Thomae Mya | Director | A Award deriv | 2016-10-06 | 2016-10-11 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Patzig Robert | Director | A Award deriv | 2016-10-06 | 2016-10-11 | 105,000 | — | $0 | 105,000 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy deriv | 2016-01-08 | 2016-01-11 | 42,941 | — | $0 | 42,941 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy deriv | 2016-01-08 | 2016-01-11 | 32,205 | — | $0 | 32,205 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy deriv | 2016-01-08 | 2016-01-11 | 64,411 | — | $0 | 64,411 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy deriv | 2016-01-08 | 2016-01-11 | 42,941 | — | $0 | 42,941 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy deriv | 2016-01-08 | 2016-01-11 | 32,205 | — | $0 | 32,205 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy deriv | 2016-01-08 | 2016-01-11 | 42,941 | — | $0 | 42,941 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy deriv | 2016-01-08 | 2016-01-11 | 32,205 | — | $0 | 32,205 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy deriv | 2016-01-08 | 2016-01-11 | 85,882 | — | $0 | 85,882 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2016-01-06 | 2016-01-11 | 288,659 | — | $0 | 0 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2016-01-06 | 2016-01-11 | 577,319 | — | $0 | 0 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2016-01-06 | 2016-01-11 | 517,241 | — | $0 | 0 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2016-01-06 | 2016-01-11 | 577,319 | — | $0 | 0 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2016-01-06 | 2016-01-11 | 1,034,482 | — | $0 | 0 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion deriv | 2016-01-06 | 2016-01-11 | 1,034,482 | — | $0 | 0 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion | 2016-01-06 | 2016-01-11 | 344,822 | — | $0 | 653,018 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy | 2016-01-06 | 2016-01-11 | 894,965 | $1.00 | $895.0K | 1,510,135 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion | 2016-01-06 | 2016-01-11 | 461,072 | — | $0 | 615,170 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy | 2016-01-06 | 2016-01-11 | 1,472,636 | $1.00 | $1.47M | 2,125,654 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy | 2016-01-06 | 2016-01-11 | 317,294 | $1.00 | $317.3K | 894,613 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion | 2016-01-06 | 2016-01-11 | 922,141 | — | $0 | 1,230,337 | SEC↗ |
| KIRK RANDAL J | 10% Owner | P Buy | 2016-01-06 | 2016-01-11 | 1,789,930 | $1.00 | $1.79M | 3,020,267 | SEC↗ |
| KIRK RANDAL J | 10% Owner | C Conversion | 2016-01-06 | 2016-01-11 | 577,319 | — | $0 | 577,319 | SEC↗ |
| Thomae Mya | Director | A Award deriv | 2015-06-08 | 2015-06-10 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Patzig Robert | Director | A Award deriv | 2015-05-12 | 2015-05-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Koppler Doit II | Director | A Award deriv | 2015-04-01 | 2015-04-02 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Kinnon Paul | CEO, President and Interim C | A Award deriv | 2015-04-01 | 2015-04-03 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Patzig Robert | Director | A Award deriv | 2015-04-01 | 2015-04-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Richards Leon | Chief Accounting Officer | A Award deriv | 2015-04-01 | 2015-04-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Luther Michael A | Director | A Award deriv | 2015-04-01 | 2015-04-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| THOMPSON JOHN D | Director | A Award deriv | 2015-04-01 | 2015-04-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Richards Leon | Chief Accounting Officer | A Award deriv | 2014-11-04 | 2014-11-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Richards Leon | Chief Accounting Officer | A Award deriv | 2014-11-04 | 2014-11-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kopp LeRoy C | 10% Owner | S Sale | 2014-05-22 | 2014-05-23 | 413,050 | $3.70 | $1.53M | 0 | SEC↗ |
| THOMPSON JOHN D | Director | G Gift deriv | 2014-05-14 | 2014-05-16 | 5,000 | — | $0 | 0 | SEC↗ |
| THOMPSON JOHN D | Director | G Gift deriv | 2014-05-14 | 2014-05-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| THOMPSON JOHN D | Director | A Award deriv | 2014-05-14 | 2014-05-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Luther Michael A | Director | A Award deriv | 2014-03-13 | 2014-03-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Kopp LeRoy C | 10% Owner | P Buy | 2013-10-02 | 2013-10-04 | 9,000 | $0.39 | $3.5K | 4,956,600 | SEC↗ |
| Kinnon Paul | CEO and President | A Award deriv | 2013-09-30 | 2013-10-03 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Kinnon Paul | CEO and President | A Award deriv | 2013-09-30 | 2013-10-03 | 2,150,000 | — | $0 | 2,150,000 | SEC↗ |
| COLONNESE MARK P | Chief Financial Officer | A Award deriv | 2013-09-30 | 2013-10-03 | 690,000 | — | $0 | 690,000 | SEC↗ |
| COLONNESE MARK P | Chief Financial Officer | A Award deriv | 2013-09-30 | 2013-10-07 | 660,000 | — | $0 | 660,000 | SEC↗ |
| Kopp LeRoy C | 10% Owner | S Sale | 2012-01-06 | 2012-01-10 | 25,000 | $1.24 | $31.0K | 4,947,600 | SEC↗ |